about
Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disordersAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic reviewComparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disordersThe Pine River statement: human health consequences of DDT useCurrent concepts in the pathophysiology and treatment of aplastic anemiaOcular manifestations of idiopathic aplastic anemia: retrospective study and literature review.Comparison of pesticide exposure and physical examination, neurological assessment, and laboratory findings between full-time and part-time vegetable farmers in the PhilippinesAlternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic reviewExpression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemiaBone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.Risk of aplastic anemia and pesticide and other chemical exposures.Aplastica anemia and viral hepatitisOptimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeSevere fatigue: could it be aplastic anemia?Identification and functional characterization of novel telomerase variant alleles in Japanese patients with bone-marrow failure syndromes.Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemiaModel-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children.Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.Cytogenetic profile of aplastic anaemia in Indian children.Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.Genetic and environmental factors influencing human diseases with telomere dysfunction.Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.Exposure to p,p'-DDE Induces Morphological Changes and Activation of the PKCα-p38-C/EBPβ Pathway in Human Promyelocytic HL-60 CellsCommon polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients.What's all the fuss about? facts and figures about bone marrow failure and conditions.Multiple synchronous primary malignancies induced by benzene exposure: a case report.Application of veterinary antibiotics in China's aquaculture industry and their potential human health risks.Incidence and outcome of acquired aplastic anemia-real-world data from patients diagnosed in Sweden from 2000-2011.Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.Pattern of haematological diseases diagnosed by bone marrow examination in Yemen: a developing country experience.Epidemiological Features of Aplastic Anemia in Indian Children.Aplastic anemia associated with pregnancy: maternal and fetal complications.Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.High incidence of aplastic anemia is linked with lower socioeconomic status of Indian population.Validation of diagnosis of aplastic anaemia in La Rioja (Spain) by International Classification of Diseases codes for case ascertainment for the Spanish National Rare Diseases Registry.The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.Diagnosis and treatment of acquired aplastic anaemia in adults: 142 cases from a multicentre, prospective cohort study in Shanghai, China.Scientific Opinion on Chloramphenicol in food and feed
P2860
Q24186615-3B496224-1CBD-47CC-8B88-0AE983B2509BQ24186703-7721F998-6529-4921-BBD7-8364EEE6BBEDQ24187692-A00A6098-EA21-4CEC-B9F0-2729CBC66378Q24642941-C2F94B2C-3487-45F5-805E-C6FF16FE05A8Q24685812-C5BFECB2-3436-4CDB-8832-AA4EF3F47FECQ27690860-39906194-8FB7-45DD-971A-7B72D4B93D1AQ28391750-2C355DFF-BF56-4C82-A9AD-E5B99ECEC79CQ33436416-6FA61D6D-450D-431E-9E82-39A59AEF650BQ33660516-21C3A5A3-C0B2-46C6-8876-6EC23A2A054BQ33828556-54C76E52-CA5D-4DCE-87BE-03EBE5993731Q33871963-CABA035A-152E-45AA-A099-EB5A90ACF2D6Q34549277-287CEE08-4392-4AA9-AE7E-C09A12F787F8Q34645147-E6BF48B8-6526-47B9-BF29-377355D3E948Q34989207-7F0DEF6E-105A-4FDC-A224-BD51A9945C15Q35282415-62D641F0-6E65-4E6F-A45D-840F475A41C0Q35602992-66AB5646-14E4-4B92-8AAD-840AF7E76E8AQ35669193-87E2D0B6-8FFF-4069-8055-963738E98BD2Q35967925-604EB0AB-F461-4298-877A-63045DC8FD2BQ36009002-F6CDFC2E-8C5B-4D35-B6C3-24A20192E526Q36782730-E17B0ACF-55EB-413E-BFFA-BD6206C26413Q36994933-8588C0DC-94E7-4329-9BBE-A2277BBE5EF0Q37265484-69824890-0668-4F27-9AF4-3EC9734ADC8AQ37285981-3FC1CF5D-BE00-4A8E-A47D-A0499E86D2B6Q37334938-01FF3036-89D0-4EE5-B9F3-35C59E7EE173Q37385812-F95AEF00-0C3D-4EDA-99C9-83F6C4D293B9Q37698002-F4A3BB9A-191C-4C14-A8FB-0DAE5985C686Q38039381-059E58C4-63CE-44A5-99B4-3EA4F5BECA27Q38450939-A3F7448F-C062-49AD-92AA-4FA8B3DBADB1Q38615899-F1630F6B-E806-4B70-AF0C-82543EF673F3Q38656500-55D186B8-D5B8-49A2-A782-5EB2A4120377Q38700958-C07FB62B-7A2A-4AAC-BC6A-ED8FC9C923DBQ39194726-2EBF044F-963C-4E49-9990-8C1FE4E87EC2Q40231656-EF549F9A-AD10-48F0-8932-F8C65E99AC3FQ40537984-8C9E818B-8280-4F04-84E9-B976A22FB4D5Q40668046-CC82222A-E208-4B11-AC3E-71F937F02B7DQ41258937-EDC1AB63-530E-490D-A75C-ED8AE89A30C5Q44262264-DD2AF4F1-8C12-482E-935B-96573DB1FD1EQ44434880-3A221867-3F21-4614-8B2D-0121C8D033DCQ46725055-D1858810-5815-4204-85C7-52183AC311C5Q47163096-9192BAE6-9392-40B9-8CC6-D47C0D5B7BC7
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The epidemiology of aplastic anemia in Thailand.
@ast
The epidemiology of aplastic anemia in Thailand.
@en
type
label
The epidemiology of aplastic anemia in Thailand.
@ast
The epidemiology of aplastic anemia in Thailand.
@en
prefLabel
The epidemiology of aplastic anemia in Thailand.
@ast
The epidemiology of aplastic anemia in Thailand.
@en
P2093
P2860
P1433
P1476
The epidemiology of aplastic anemia in Thailand.
@en
P2093
Kanchana Chansung
Neal S Young
Paul E Leaverton
Samuel Shapiro
Theresa Anderson
P2860
P304
P356
10.1182/BLOOD-2005-01-0161
P407
P577
2005-10-27T00:00:00Z